Chase AIPricingFAQs
Display currency
Loading news…

BioBlast Pharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Tel Aviv, Israel Founded 2012 11-50 employees For Profit

Bio Blast Pharma, a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1
Ticker
ORPN
NASDAQ
Patents
3

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Public
Ticker
ORPN
Exchange
NASDAQ
IPO date
Jul 31, 2014
Raised at IPO
$35M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
31
Active products
11
Patents granted
3
Trademarks
0
Top patent class
a61

Company Info

Founded
2012
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
2
HQ
Tel Aviv, Israel
Region
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
Exit date
Jul 31, 2014

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.1
Trend (30d)
-0.4
Trend (90d)
0
1
professional contacts at BioBlast Pharma
Contact execs at BioBlast Pharma

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to BioBlast Pharma

Loading news…

FAQs about BioBlast Pharma

People who checked this page also checked these

Browse the full Acquirezy directory.
BioBlast Pharma - Company Profile, Full Acquisitions List, Funding and Investments